Positive Phase 3 Results For New Fixed Oral Dose Anticoagulant Presented At 48th Annual Meeting Of The American Society Of Hematology

... Positive results from RE-MODEL(TM), a phase 3, randomized, parallel-group, double-blind, active controlled study investigating the efficacy and safety of two different dosing strengths of orally administered dabigatran etexilate capsules compared to subcutaneous injection of the low molecular [click link for full article] ...